Peoria, IL – July 9, 2013 – Endotronix is pleased to announce that Sam Leno has recently been elected to the Endotronix Board of Directors. Leno has over 40 years of experience in a variety of leadership positions principally in Fortune 500 global healthcare-related companies with multi-billion dollar business units.
“Sam’s experience as a senior executive at some of the world’s largest healthcare companies will have a significant impact at Endotronix as we execute our innovative global strategies,” said Jim Hummer, Endotronix Chairman. “His perspective on finance, operations, and business development will be important as Endotronix develops and deploys transformational technology and solutions to our customers.”
“I am very excited to be joining the Endotronix board. The leadership team is exceptional and the patented technology under development is expected to surpass any competitive products in this critical market,” said Leno.
Prior to joining Endotronix, Leno had been Executive Vice President and Chief Operations Officer of Boston Scientific Corporation, a position from which he retired in December, 2011. In this role he was responsible for the finance, information systems, operations, business development, and strategy functions. He served as Executive Vice President, Finance and Information Systems and Chief Financial Officer of Boston Scientific from 2007 until March 2010.
Previously, Leno was Executive Vice President – Corporate Finance and Operations and Chief Financial Officer of Zimmer Holdings, Inc. from 2003 to 2007, and Senior Vice President and Chief Financial Officer of Zimmer from 2001 to 2003. From 1999 to 2001, Leno served as Senior Vice President and Chief Financial Officer of Arrow Electronics, Inc. He also served as Chief Financial Officer of Corporate Express, Inc. and Coram Healthcare. In previous positions for over 20 years, Leno served in various financial and executive capacities at Baxter International Inc. and American Hospital Supply Corporation, both global healthcare companies.
Leno currently serves on the Board of Directors of Omnicare, Inc. and Lantheus MI Holdings, Inc., and previously served on the Board of Directors of TomoTherapy Incorporated. He also serves on the Healthcare Initiative Advisory Board of the Harvard Business School. Prior to beginning his business career, Leno served as a Lieutenant in the United States Navy and is a Vietnam veteran. Leno holds a Bachelor of Science degree in Accounting from Northern Illinois University and an MBA from Roosevelt University.
About Endotronix
Endotronix (www.endotronix.com) develops digital health solutions with the goal of enhancing the quality of life, improving outcomes, and lowering costs, especially for the 20 million people worldwide who suffer from heart failure. Endotronix was founded in 2007 by Anthony Nunez, M.D., and mechanical engineer Harry Rowland, Ph.D. The company has a suite of technology patents supporting its innovative care management solutions. Endotronix is a privately funded company pursuing its CE Mark and European market introduction.
For more information about Endotronix, contact media@endotronix.com or G.A. Poole, -30- Agency at 630-473-3200 ext 201.
Download the Full Release